Counselors in Atmore, AL Accepting Medicare

6 Counselors found. Showing 1 - 6

Ms. Kathleen Fox Sellers, LPC Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 309 E Ridgeley St, Atmore, AL 36502 Phone: 252-368-1675    Fax: 251-446-1994

Rachel L Chambers, COUNSELOR (ALC) Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 204 S Pensacola Ave, Atmore, AL 36502 Phone: 251-359-0201

Ms. Cordia C Lee, ALC Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 213 Adams St, Atmore, AL 36502 Phone: 251-359-1904

Ann Marie Nowak Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 100 N Main St, Atmore, AL 36502 Phone: 205-575-3611

Latisha Sharnice Dailey Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 150 Patterson St, Atmore, AL 36502 Phone: 251-359-6459

Mrs. Clarissa Shawn Mcreynolds, MS, NCC, LPC Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 3421 Highway 21, Atmore, AL 36502 Phone: 251-333-2777    Fax: 251-241-7202

News Archive

Highly-infectious sickness bug can be killed by copper and copper alloys

New research from the University of Southampton shows that copper and copper alloys will rapidly destroy norovirus - the highly-infectious sickness bug. The virus can be contracted from contaminated food or water, person-to-person contact, and contact with contaminated surfaces, meaning surfaces made from copper could effectively shut down one avenue of infection.

Ipsen's Somatuline Depot Injection 120 mg receives FDA approval for treatment of GEP-NETs

Ipsen Biopharmaceuticals, Inc., an affiliate of Ipsen, today announced that Somatuline Depot (lanreotide) Injection 120 mg (referred to as Somatuline) was approved by the U.S. Food and Drug Administration for the treatment of gastroenteropancreatic neuroendocrine tumors (GEP-NETs) in adult patients with unresectable, well or moderately differentiated, locally advanced or metastatic disease to improve progression-free survival (PFS).

More than 22,000 Americans expected to be diagnosed with a malignant brain tumor in 2009

It is expected that more than 22,000 Americans will be diagnosed with a malignant brain tumor in 2009. Senator Ted Kennedy's death from a brain cancer draws attention to a rare, but often fatal type disease. While the risk of developing brain cancer is relatively low, it is important to heed the warning signs and receive an accurate diagnosis.

Resveratrol suppresses inflammation and free radicals: Study

Resveratrol, a popular plant extract shown to prolong life in yeast and lower animals due to its anti-inflammatory and antioxidant properties, appears also to suppress inflammation in humans, based on results from the first prospective human trial of the extract conducted by University at Buffalo endocrinologists.

Medicare official defends proposed changes to prescription drug program

In written testimony, Jonathan Blum, deputy administrator of the Centers For Medicare & Medicaid Services, says the changes are needed to head off cost increases, but an industry-sponsored study argues some of the changes could cost taxpayers more.

Read more Medical News

› Verified 6 days ago